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Abstract. Bursts of actin polymerization in vivo in- 
volve the transient appearance of free barbed ends. To 
determine how rapidly barbed ends might appear and 
how long they might remain free in vivo, we studied the 
kinetics of capping protein, the major barbed end cap- 
per, binding to barbed ends in vitro. First, the off-rate 
constant for capping protein leaving a barbed end is 
slow, predicting a half-life for a capped barbed end of 
~30 min. This half-life implies that cells cannot wait for 
capping protein to spontaneously dissociate from 
capped barbed ends in order to create free barbed 
ends. However, we find that phosphatidylinositol 4,5- 
bisphosphate (PIP2) and phosphatidylinositol 4-mono- 
phosphate (PIP) cause rapid and efficient dissociation 
of capping protein from capped filaments. PIP2 is a 
strong candidate for a second messenger regulating ac- 
tin polymerization; therefore, the ability of PIP2 to re- 
move capping protein from barbed ends is a potential 
mechanism for stimulating actin polymerization in vivo. 
Second, the on-rate constant for capping protein bind- 
ing to free barbed ends predicts that actin filaments 
could grow to the length of filaments observed in vivo 
during one lifetime. Third, capping protein [3-subunit 
isoforms did not differ in their actin binding properties, 
even in tests with different actin isoforms. A major hy- 
pothesis for why capping protein 13-subunit isoforms ex- 
ist is thereby excluded. Fourth, the proposed capping 
protein regulators, Hsc70 and S100, had no effect on 
capping protein binding to actin in vitro. 
C 
ONTROL of actin assembly is essential for cell loco- 
motion and rapid changes in cell shape. One hy- 
pothesis for regulating the location and dynamics 
of actin polymerization in vivo is to alter the availability of 
free  actin filament barbed  ends  near  the  plasma  mem- 
brane. In vitro, the barbed end of an actin filament is the 
end favored for actin polymerization and, thus, is a likely 
site for rapid actin polymerization in cells. Upon stimula- 
tion of several types of cells, increased numbers of free 
barbed ends correlate with increased actin polymerization. 
The polymerization is sensitive to cytochalasin and, there- 
fore, involves barbed ends (7, 24, 25, 46). 
Most actin filament barbed ends are not freely accessi- 
ble in cells (25, 34) and are likely blocked from elongation 
by the barbed  end binding protein, capping protein  (18, 
53). Knowing the dynamics of capping protein binding to 
F-actin  and  the  intracellular  concentrations  of  capping 
protein and actin would enable us to predict the half-lives 
of free and capped barbed ends in cells and to predict how 
capping protein participates in regulating actin assembly. 
Therefore, we determined the kinetic rate constants for 
actin binding of capping protein from muscle (CP-131) and 
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vertebrate  nonmuscle tissues (CP-132). (The  name "cap- 
ping protein," given to the first member of this family of 
barbed end actin binding proteins [34a], is used here to re- 
fer to the vertebrate homologue. To differentiate the ver- 
tebrate capping protein isoforms, we use the name CP-131, 
for capping protein containing the  131-subunit  [CP-131 is 
also  known  as  CapZ  because  of its  location  at  Z-disks 
{11}], and CP-132, for capping protein containing the 132- 
subunit.) 
We also investigated potential signals proposed to regu- 
late the actin binding activities of capping protein. Regu- 
lated uncapping of actin filaments is an attractive mecha- 
nism for increasing the  number  of free  barbed  ends  in 
response  to extracellular signals.  Capping protein  is  re- 
leased from the actin cytoskeleton upon platelet activation 
(47),  consistent with uncapping. In addition, the mainte- 
nance  of uncapped filament barbed  ends  at the  rear  of 
Listeria has been proposed as one mechanism for the actin 
assembly that drives movement of the bacterium (44). 
Polyphosphoinositides have been proposed to mediate 
actin  assembly (37);  in  particular,  uncapping  of barbed 
ends by phosphatidylinositol 4,5-bisphosphate (PIP2) 1 has 
1. Abbreviations  used in this paper:  PA, phosphatidic acid; PE, phospha- 
tidylethanolamine;  PI,  phosphatidylinositol;  PIP,  phosphatidylinositol 
4-monophosphate;  PIP2,  phosphatidylinositol  4,5-bisphosphate,  PIP3, 
phosphatidylinositol, 3,4,5-trisphosphate. 
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bly  in  activated  platelets  (27).  Therefore,  we  tested  the 
ability of phosphoinositides to promote dissociation of cap- 
ping protein  from  F-actin.  Hsc70  (21,  28)  and  S100 pro- 
teins (35, 36) also have been reported to interact with capping 
protein,  but  their  effects  on  actin  binding  using  purified 
components are not known. Therefore, we tested whether 
or  not  Hsc70  and  S100  proteins  affect  the  actin  binding 
properties of capping protein. 
Vertebrates have two isoforms of the capping protein 13 
subunit. CP-[31 is the predominant capping protein of mus- 
cle and is found at Z-disks of sarcomeres (11). CP-132 is the 
predominant  isoform  in nonmuscle  tissues.  CP-132 also  is 
expressed in small amounts in muscle cells, where it is dis- 
tributed at the cell periphery, but not at Z-disks (54). The 
two  13  subunits  arise  from  alternatively  spliced  mRNA 
transcripts  and  only  differ  in  ~30  amino  acids  at  their 
COOH termini. The different COOH-terminal amino acid 
sequences are presumed to be important because they are 
highly conserved among vertebrates. Since the COOH ter- 
minus of the 13 subunit is necessary for binding actin (33), 
we hypothesized that the isoforms differ in their actin bind- 
ing properties.  For example, binding of CP-[31 to F-actin 
may be highly stable in order to stabilize the actin filaments 
of the sarcomere. On the other hand, binding of CP-132 to 
F-actin may be dynamic to regulate the rapid polymeriza- 
tion  of cortical  actin  filaments  important  for  locomotion 
and changes in shape. A corollary to this hypothesis is that 
the actin-binding properties of capping protein  [3 subunit 
isoforms  may be differentially modulated  by cellular fac- 
tors such as PIP2, Hsc70, and S100 proteins. 
An alternate hypothesis to account for the existence of 
two  13 subunit isoforms  is that CP-[31 and  CP-132 interact 
selectively with  different  isoforms  of actin.  The  distribu- 
tions  of  CP-[31 to  sarcomeres  and  CP-132 to  the  cortex 
within single cardiomyocytes (54) parallel the distributions 
of sarcomeric (a-actin) and nonsarcomeric (13- and 3,-actins) 
actins  (16,  31,  48).  Therefore,  CP-131 may  preferentially 
bind a-actin and CP-[32 may preferentially bind [?,3,-actin. 
To test the hypotheses that (a) the actin binding properties 
of CP-131 and CP-132 are different or are differentially reg- 
ulated, and (b) that CP-[31 and CP-132 interact differentially 
with actin isoforms, we purified capping protein from chicken 
kidney  (CP-132), from  chicken  brain  (CP-[32),  and  from 
chicken pectoral muscle (CP-131) and compared their actin 
binding activities using actin from skeletal muscle (a-actin), 
from erythrocytes (13-actin), and from brain (133,-actin). 
Materials and Methods 
Proteins, Reagents, and Antibodies 
Capping protein  of chicken skeletal muscle  (CP-[31) was purified  as de- 
scribed  (6).  ¢~-Actin from  chicken  skeletal  muscle  was  purified  as  de- 
scribed  (55).  Pyrene-labeled actin  was prepared  as described  (13).  Non- 
muscle actins were purified from bovine erythrocytes ([3-actin)  and from 
chicken brain ([3~-actin)  according to a method based on DNase I affinity 
chromatography (40).  Spectrin-F-actin seeds were prepared as described 
(10). Bovine heat-shock cognate protein-70 (Hsc70) and monoclonal anti- 
Hsc70 were obtained from StressGen Biotechnologies (Victoria, BC, Can- 
ada).  Cytochalasin  D  and  S-100  proteins  (S100A,  S100B,  and  S100aa) 
were obtained from Sigma Chemical Co. (St. Louis, MO), PIPz was pur- 
chased  from  Sigma  Chemical  Co.  (sodium  salt)  and  from  Boehringer- 
Mannheim Corp. (ammonium salt; Indianapolis, IN); both sources of PIPa 
had  identical  effects  in  the  actin-binding  assays.  Phosphatidylethanol- 
amine (PE), phosphatidylinositol  4-monophosphate  (PIP), phosphatidyl- 
inositol  (PI),  and  phosphatidic  acid  (PA)  were  obtained  from  Sigma 
Chemical Co. Phosphatidylinositol 3,4,5-trisphosphate (PIP3) was a gener- 
ous gift from  Dr.  C.-S.  Chen  (University of Kentucky,  Frankfort,  KY) 
(22). All lipids stock solutions were prepared by sonication at 1 mg/ml in 
H20 and stored at -70°C; aliquots were sonicated for 20 min in a water 
bath sonicator before use. 
mAbs 3F2 and 5B12 were prepared in this laboratory and were purified 
from ascites fluid using protein A-agarose. mAb 3F2 was elicited in mice 
by immunization with a fusion protein of glutathione-S-transferase (GST) 
and the unique 27 COOH-terminal amino acids of chicken capping pro- 
tein [32 subunit, mAb 5B12 was elicited in mice by immunization with a fu- 
sion protein of GST and the chicken ~1 subunit, mAb 3F2 reacts with the 
[32 subunit,  but  not  the  [31  subunit  of chicken  capping  protein  (Fig.  1); 
mAb 5B12 reacts with c~l and ct2 subunits of chicken capping protein (Fig. 1  ). 
mAb 1E5 is specific for chicken capping protein [31 subunit (33, 54). 
Electrophoresis and Immunoblotting 
SDS electrophoresis  was performed as described  (42).  Two-dimensional 
(2-D) gels and immunoblots were performed as described  (54); 2-D gels 
were stained using the Silver Stain Plus reagent (BioRad Labs, Hercules, 
CA)  as described  by the manufacturer.  Dot blots used  to assay column 
fractions were performed by applying 1-2 txl of the column fractions to a 
nitrocellulose filter. The filter was air-dried and reacted with antibodies as 
for immunoblots. 
Purification of Capping Protein (CP-fl2) of Kidney 
and Brain 
CP-[32 was purified  from chicken  kidney  and  from chicken  brain  using 
methods  similar to  the protocol  for purification  of CP-[31 from skeletal 
muscle (6). Tissue was frozen in liquid N2 (Pel-Freez Biologicals, Rogers, 
AK) and stored at  -70°C until use. Approximately 100 g of brain or kid- 
ney was  homogenized  per  1 liter of 0.6  M  KI, 20  mM  Na2SzO3, 5  mM 
2-mercaptoethanol,  1  mM  NAN3, and  the  protease  inhibitors  0.1  mM 
PMSF, 0.1  IxM pepstatin  A, 0.1  ixM leupeptin,  and 0.1  mM benzamidine 
using a polytron. The homogenate was centrifuged at 25,400 g for 30 min, 
and the resulting supernatant was centrifuged at 100,000 g for 1 h. The su- 
pernatant  was dialyzed and chromatographed  on  DEAE-cellulose (DE- 
53; Whatman, Maidstone, England) as described (6). The capping protein 
fraction was subjected to (NH4)2SO4 fractionation  and chromatographed 
on Sephacryl S-200  (6). Pooled fractions were dialyzed against buffer H 
(10 mM KH2PO4,  pH 7.0, 50 mM KCI, 0.5 mM DTT, and 0.01%  NAN3), 
and the  dialysate was applied  to a  2.5  x  12-cm  column of Bio-Gel HT 
(BioRad  Labs)  equilibrated  in  buffer H.  The  column  was  washed  with 
~-,100 ml buffer H  and eluted with  a 600-ml  linear gradient  of KHzPO4 
from  10-400  mM  in  buffer  H.  The  CP-[32 was  chromatographed  on  a 
MonoS column (6), dialyzed against buffer M (10 mM Tris-Cl, pH 8.0, 1 
mM EDTA, 0.5 mM DTT, and 0.1 mM PMSF), and applied to a MonoQ 
column. The column was eluted with a linear gradient from 04).35 M KC! 
Figure 1.  mAb  5B12  and  mAb  3F2  are 
specific for the a-subunits and the 132 sub- 
unit  of  chicken  capping  protein,  respec- 
tively.  Western  blots  containing  fusion 
proteins of glutathione-S-transferase (GST) 
and the od  subunit (GST-al), the c~2 sub- 
unit  (GST-a2)  and  GST  alone  were  re- 
acted  with  mAb  5B12;  mAb  5B12  reacts 
with  the  ~1-  and  ~2  subunits.  Western 
blots  containing  fusion  proteins  of  GST 
and the 131 subunit (GST-131),  GST and 27 
COOH-terminal  amino  acids  of  the  [32 
subunit  (GST-[32), and  GST  alone  were 
reacted  with  mAb  3F2;  mAb  3F2  reacts 
with the COOH-terminal region of the 132 
subunit,  but  not with  the 131  subunit.  Nei- 
ther mAb 5B12 nor mAb 3F2 reacted with 
GST. 
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noblots of SDS gels using mAbs 3F2 and 5B12. 
The purity of CP-[32 and a comparison of the subunit compositions of 
capping protein of skeletal muscle and kidney are documented in silver- 
stained, 2-D gels (Fig. 2). CP-[31 from skeletal muscle contains the al- and 
a2-subunits in a molar ratio of ~l:l and the 131 subunit (including a modi- 
fied form of the [31 subunit called 131 ') (6, 54). CP-[32 from kidney has two 
c~ subunits, cd and a2 in a ratio of ~1:2, and the 132 subunit; CP-[32 from 
brain had an identical subunit composition. Immunoblots of identical gels 
probed with antibodies specific for c~ subunits (mAb 5B12), the 131 subunit 
(mAb 1E5), and the 132 subunit (mAb 3F2) confirmed the identification of 
these protein spots (data not shown). 
A minor protein component migrating in the 2-D gel with a mobility in 
the SDS dimension like that of the a  subunits but having a more basic iso- 
electric point was detected in the capping protein preparations from kid- 
ney and skeletal muscle (labeled c~3? in Fig. 2); this protein reacted on im- 
munoblots  probed  with  mAb  5B12  (data  not  shown).  This  minor 
component may be the chicken homologue of a protein of mouse testicu- 
lar germ cells that was identified by cDNA cloning and is similar to cap- 
ping protein a  subunits (56); the predicted isoelectric point of the mouse 
protein (pl =  6.7) is consistent with that of the protein we tentatively des- 
ignate the c~3 subunit on the 2-D gels. 
Critical Concentration Measurements and 
Determination of  Dissociation Constants (Kd) 
The effect of capping protein on the steady-state actin filament concentra- 
Figure 2.  Silver-stained  two-dimensional gels of CP-131  purified 
from  chicken  pectoral  muscle  (upper gel)  and  CP-[32  purified 
from chicken kidney (lower gel). The positions of the individual 
capping protein subunits were identified by reaction with t~- and 
[3-specific antibodies  and from  the predicted  mobilities of the 
subunits (15).  The  major  difference  in  subunit composition  be- 
tween the capping protein isoforms is the 13 subunit: CP-[31  con- 
tains the 131 subunit ([31 and 131') and CP-132 contains the 132 sub- 
unit. Preparations  of both capping protein  isoforms contained  a 
small  amount  of  a  putative,  novel  a  subunit  protein  we  tenta- 
tively label "c~3?" based on its reaction with mAb  5B12 (data not 
shown). 
tion for skeletal muscle ~-actin and erythrocyte 13-actin were determined 
by incubation of 1 ~M c~- or [3-actin (each containing 10% pyrene-labeled 
~-actin as a tracer for polymerization) in MKEI buffer (0.1  M KCL 2 mM 
MgCI2,  1 mM EGTA and 20 mM imidazole-HCl, pH  7.0)  with varying 
concentrations of CP-[31 and CP-[32. Samples were incubated for 24 h  at 
room temperature with gentle rocking and pyrene fluorescence was mea- 
sured (13). The Kd for capping protein binding to actin was determined 
from the amount of capping protein that changes the critical concentra- 
tion by 50%  as described (58)  using elongation rate constants for ATP- 
actin (50). 
Actin Polymerization Assays 
Actin polymerization from spectrin-F-actin seeds was assayed using 1.5 
IxM actin (5 or 10% pyrene labeled), 0.054--0.25 nM spectrin-F-actin seeds 
and varying concentrations of CP-[3I  or CP-132 in  MKEI  buffer. Mono- 
meric actin was diluted to  1.5 txM in MKEI buffer and preincubated for 
160 s to allow exchange of Mg  z+ for Ca  2+ on the actin. Spectrin-F-actin 
seeds and either CP-131 or CP-[32 were added to the cuvette and pyrene 
fluorescence (5) was monitored for up to 1,040 s. Assays were performed 
at 25°C. 
Actin Uncapping  Assay 
The uncapping assay was a modification of the actin polymerization assay 
using 0.23 nM spectrin-F-actin seeds, 2 ~M actin (5% pyrene labeled) and 
varying concentrations of CP-[31 or CP-132. The buffer was 0.l MKEI (0.1 
M  KCI, 0.2 mM MgCl2,  0.1  mM EGTA, and 20 mM imidazole-HCl, pH 
7.0), which was determined to be optimal for PIP2-mediated uncapping. 
The reaction  was initiated by the addition of the spectrin-F-actin seeds 
and capping protein to monomeric actin in 0.1 MKEI. Phospholipids were 
added to the polymerization reaction at 340 s and the fluorescence was 
monitored for a total of 1,200 s. Assays were performed at 25°C.  Assays 
were performed using Hsc70 and S-100b in place of phospholipids to test 
whether these proteins induced uncapping. In some experiments, actin fil- 
aments capped by CP-[31 were used in place of spectrin-F-actin seeds. The 
capped filaments were  prepared  by mixing 0.11  izM CP-[31 and  11  I~M 
c~-actin in 0.1 MKEI buffer overnight at room temperature. To test mixed 
micelles of PIP2 and PE, PIP2 and PE were mixed in molar ratios of 1:3 to 
l:100, sonicated in a bath sonicator for 15 min and added to uncapping as- 
says so that the final concentration of phospholipid was 100 ~tM. 
Determination of the Rate Constants for 
Capping F-actin 
The rate constants for capping actin filaments were determined from data 
collected in actin polymerization assays using the kinetic parameter opti- 
mization programs, KINSIM  (3)  and FITSIM  (61).  The kinetic mecha- 
nism used for the simulation was steps 1 and 2 of the mechanism shown 
below, where A  is actin monomer, AN is the number of actin filaments 
and also equals the number of speetrin-F-actin seeds, C  is capping pro- 
tein, and PIP2 is itself. 
A +  AN  ~-~ AN  (1) 
AN+C  ~  ANC  (2) 
C +PlP 2  ~  CPIP  2  (3) 
ANC +  PIP 2  7:2 ANCPIP  2  (4) 
AN +  CPIP  2 ~_~ ANCPIP  2  (5) 
The concentration of spectrin-F-actin seeds was determined by fitting 
the  experimental  data  obtained  for  seeded  polymerization  of a-actin 
alone using KINSIM  and the on-rate and off-rate constants for muscle 
a-actin, 11.6  ~M-~s  -I and 1.4 s -~, respectively (50).  The on-rate and off- 
rate constants for [3-actin were determined using KINSIM and the critical 
concentration for [3-actin (determined experimentally to be 0.16 ~M); the 
on-rate and off-rate constants for nonmuscle actin were 10.0 p,M  ~s  ~  and 
1.6 s  ~, respectively. This mechanism assumes that there is no pointed end 
growth from the spectrin-F-actin seeds. To confirm this assumption, we 
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ter addition of the seeds in the presence of 20 nM cytochalasin D. 
For kinetic  simulations of the action of PIPz on capped filaments, steps 
1-5  of the mechanism shown above were used.  The on-rate and off-rate 
constants assigned for step 1 were 11.6 IxM  ts-~ and 1.4 s  -t, respectively, 
and for step 2 were 3.6  IxM  is-1  and 4.0  X  10 -4  S -1,  respectively.  Rate 
constants for steps 3-5 were varied over a wide range to obtain simulated 
progress curves using KINSIM, which were compared with the  experi- 
mental data for actin polymerization in the presence of capping protein 
and PIP2. 
Actin Depolymerization Assay 
F-actin  at  5  IxM  (40-50%  pyrene-labeled)  was  mixed  with  varying 
amounts of CP-[31 or CP-132, incubated 5 min at room temperature, and 
diluted 25-fold into G buffer (2 mM Tris-Cl, pH 8.0, 0.2 mM ATP, 0.1 mM 
dithiothreitol, 0.2 mM CaCI2, and 0.005%  NAN3) at 25°C in a fluorometer 
cuvette with a stirring bar (5). The decrease in pyrene fluorescence accom- 
panying actin depolymerization  was monitored for 300 s after dilution.  To 
test the  effects  of PIPe,  phosphatidylinositol 3,4,5-trisphosphate Hsc70, 
and S-100 proteins on capping activity,  50 nM CP-[31 or CP-132 was incu- 
bated for 5 min with varying concentrations of the test reagent before ad- 
dition to F-actin.  The effects of Hsc70 were measured in the presence of 5 
mM ATP or 5 mM ADP and 5 mM MgCI2. The effects  of S-100 proteins 
were measured in the presence and absence of CaCI; at 0.2-1 mM. 
Actin Nucleation Assay 
Monomeric actin  at 5 txM (10% pyrene labeled) was incubated with CP- 
131 or CP-132 for 5 rain in G buffer. Fluorescence of pyrene-actin was mon- 
itored after the addition of 1/10 volume of 10× MKEI to the cuvette. 
Analysis of the Interaction of CP and Hsc70 
For gel filtration analysis,  CP-132 was mixed in a final volume of 0.2 ml in 
buffer S (10 mM Tris-HCl, pH 8.0, 0.2 M KCI, 1 mM dithiothreitol, 0.01% 
NaN  3, 0.5 mM EDTA, 5 mM ADP, and 5 mM MgCI2) with Hsc70 (molar 
ratio Hsc70:CP-132 of 2:1). The mixture was applied to a Superose 12 HR 
column (1  x  30 cm) equilibrated in buffer S. Fractions were assayed for 
capping protein and Hsc70  by Western blotting using mAb 5B12,  mAb 
3F2, and anti-Hsc70.  Control runs were of Hsc70 alone and CP-132 alone. 
For immunoprecipitation analysis,  CP-131 or CP-132 was mixed in a molar 
ratio of 3:1 (Hsc70:CP)  with Hsc70 in a buffer containing 10 mM Tris-HCl, 
pH 7.4, 0.15 M NaCI, 0.1%  Triton X-100, and 0.1 mg/ml bovine serum al- 
bumin. A final concentration of either 5 mM ATP and 5 mM MgCI2 or 5 
mM ADP and 5 mM MgC12 was added to each sample. The mixtures were 
incubated for 1 h on ice; 10 Ixg of mAb 5B12, mAb 3F2, mAb 1E5, mouse 
IgG, or monoclonal anti-Hsc70  was added and incubated for 2 h. Immune 
complexes were isolated using BioMag goat anti-mouse lgG (PerSeptive 
Diagnostics, Cambridge, MA), washed eight times in 10 mM Tris-HC1, pH 
7.4, 0.45 M NaC1, 1% Triton X-100 and twice in 10 mM Tris-HCl, pH 7.4, 
0.15 M NaCI, 0.1% Triton X-100. The immune complexes were solubilized 
in SDS sample buffer and analyzed  on Western blots probed with a mix- 
ture of mAb 5B12, mAb 3F2, mAb l E5, and anti-Hsc70. 
Falling Ball Viscometry Assay 
Falling ball viscometry assays were performed at room temperature as de- 
scribed (12). 
Results 
Kinetic Rate Constants 
The  rate  constants  for binding  of CP-131 and  CP-132 to 
muscle  a-actin,  erythrocyte  13-actin, and  brain  13"y-actin 
were  determined  using  kinetic  simulations  of  the  time 
course of actin polymerization in the presence of varying 
concentrations  of CP-151 and CP-132 (Fig.  3) The on-rate 
constants (k+) and the off-rate constants (k_) for CP-~31 
and  CP-132 (Table  I)  were  similar  to  each other  and  to 
those determined for capping activity in supernatant frac- 
tions from neutrophils (18). The on-rate constant for bind- 
2.5- 
2.0- 
8~ 
~2 
o  t'n  1.o- 
0.5- 
0 
0 
cP-131 
(nM) 
•  . ,:~-'  .. 
-~"  "a~  0.24 
'~:  ;~  %  ""  • '  '  0.47 
~" -~-"~"  ~  o...-..;.'~.~  0.71  •  .~'-~-~  ...  L,,~.  -~_.'~.-~¢.,r,':*L3 
F 
 oo4 
I  I  ]  I  I 
200  400  600  800  1000 
Time (sec) 
I 
1200 
2.5- 
2.0- 
A 
8~ 
¢-  r.  1.5- 
o~  0o~. 
o ~'~'-  1.0  _=-e 
u.~ 
0.5 
CP-I32 
(riM) 
....  ~i-~-  '~,~  : 
.,~.~...~.,~.~.,-.  .-  .....  0.26  .~'*~:2~~'~':  .. ~-,~.;.. 
~"  i~  ~:  i  " ....  .~  -  ,~',~  0.53 
0.79 
--  |  {  1  i  i  3 
t  200  400  600  800  1000  1200 
Time (sec) 
Figure 3.  Effect of CP-I31  (upper) and CP-132 (lower) on actin po- 
lymerization nucleated by spectrin-F-actin seeds. The change in 
pyrene-actin fluorescence accompanying polymerization is plot- 
ted  versus time  after  addition  of the  capping protein and  spec- 
trin-F-actin seeds to a solution of 1.5  IxM tx-actin in MKEI buffer. 
The solid lines represent the simulated progress curves predicted 
from kinetic  modeling for  two  concentrations  of each  capping 
protein isoform. 
ing ct-actin was slightly higher for CP-~2 (mean value de- 
rived from three determinations  =  5.7  ixM-Is  -I) than for 
CP-131 (mean value derived from three determinations  = 
3.5  /xM-ls-l).  The  off-rate constants  for dissociation  of 
capping protein from a barbed end were low (mean value 
derived from six determinations  --  4  ×  10 -4  S-I). These 
rate constants predict that the half-life of a capped barbed 
end in cells is long (~28 rain), while the half-life for a free 
barbed end is short (~0.2 s); the implications of these half- 
lives for control of actin polymerization by capping pro- 
tein will be considered below (see Discussion). 
We also determined the dissociation constant  (Kd) for 
binding CP-131 and CP-132 to muscle and nonmuscle actins 
by measuring the ability of each isoform to alter the criti- 
cal  concentration  for  actin  polymerization  (Fig.  4).  The 
Kas for actin binding  (Table I) were nearly identical  for 
CP-[31 and CP-[~2, ranging from 0.06 _+ 0.02 to 0.13  _+ 0.02 
The Journal of Cell Biology, Volume 135, 1996  172 Table 1. Dissociation Constants and Rate Constants  for the Interaction of CP-fll and CP-fl2 with a-Actin, fl-Actin, and fly-Actin 
On-rate ~  Off-rate*  Off- rate -~ 
Ko*  constant (k+l)  constant (k_ :)  constant (k_ i) 
Capping protein isoform  Actin isoform  nM  ~M-~s- t  s-~  ×  10 -4  s- J ×  10 -4 
CP-[31  (muscle)  (expt.  1) 
(expt. 2) 
(expt. 3) 
(expt. 4) 
CP-132 (kidney)  (expt.  1) 
(expt. 2) 
(expt. 3) 
CP-[32 (brain)  (expt. 5) 
CP-132 (kidney)  (expt. 4) 
CP-[32 (brain)  (expt. 5) 
ct-actin 
et-actm 
ct-actm 
[3-actm 
a-actm 
ct-actln 
a-actln 
c~-actln 
[3-actm 
[3~/-actin 
0,08  +  0.02  3,5  +  0,2  4,4 4- 0.2  2,7 4- 0.7 
3.2 __+ 0,03  1,9 4- 0,3 
3.3  __+ 0,3  0.0 4-  11.8 
0,06  __+ 0.02  3.9  2  0,08  2.8  +  0.8  2,4 +__ 0.8 
0.13  __+ 0.02  5.8 -+ 0.03  3.7  +  0.2  7.5  ±  1,12 
5,1  +  0.04  1.2  ±  0.2 
6.5  __-_ 0,03  4.9 _____ 0.2 
5.3  --- 0.09  0.9 __ 0,3 
0.08  +  0.02  3.9 ±  0.04  9.5  ±  0.4  3.1  __ 0.8 
2.3  +  0.02  8,4 +  0.4 
*The value for the K0 was calculated from the data in Fig. 4 using the point where the amount of F-actin changed by 50% as described in Materials and Methods. The error in this 
estimate was determined by estimating the error in the individual data points for each curve and calculation of the upper and rower limits for the Kd. 
:!These on-rate and off-rate constants were determined using the simulation program FITSIM; each value is the best fit obtained using 4-5 experimental data sets. The errors are 
the errors calculated by the algorithm for each independent analysis. The determinations using ot-actin were from three independent experiments; the rate constants with i3-actin 
and 13v-actin were each determined in one experiment. 
.~This off-rate was calculated from the Ku value indicated in column 3 of lhis table and the on-rate constant (column 4 of this table) determined using FITSIM. The formula is 
Kj =  k_ i/k+ 1. 
nM, and there was no difference in the Kas for binding of 
CP-131 and  CP-132 to different  actin  isoforms.  Our values 
for the Kd are consistent with the previously published Kd 
for CP-131 binding to c~-actin,  which was reported to have 
an upper limit of 0.5-1 nM (6, 9) and with a Kd of 0.07 nM 
measured for binding human capping protein prepared by 
in vitro translation to ot-actin (2). 
Because the determination of the off-rate constant from 
kinetic simulations is not as precise as the determination of 
the on-rate constant, we also calculated the off-rate con- 
stants from the on-rate constants and the KdS (Kd =  k_/k+). 
The  values  for  these  calculated  off-rate  constants  (mean 
value from four determinations = 4 ×  10 -4 s -1) are consis- 
tent with those obtained using kinetic simulations (Table I). 
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Figure 4.  CP-131 (0) and CP-132 (©) have similar effects on the 
steady-state critical  concentration  for polymerization of muscle 
c~-actin (dotted lines) and erythrocyte 13-actin (solid lines). Actin 
at 1 p.M was incubated in MKEI buffer with varying concentra- 
tions of CP-131 or CP-[32 for 24 h at room temperature. The fluo- 
rescence of pyrene-actin is plotted versus the log of the capping 
protein concentration. 
Comparison of the Actin Binding Properties of CP-fll 
and CP-fl2 
The rate constants for CP-131 and  CP-132 binding to actin 
were similar, even in assays with different  actin isoforms. 
To verify these results, we performed three additional as- 
says that test properties different from those tested in the 
preceding experiments. First, CP-131 and CP-[32 were iden- 
tical in  their concentration  dependence  for inhibiting de- 
polymerization of F-actin  upon  dilution  (Fig. 5).  Second, 
both CP-131 and CP-I32 promoted nucleation of actin poly- 
merization (Fig. 6); CP-131 nucleated actin polymerization 
slightly better  than  CP-132. Third,  CP-[31  and  CP-[32 had 
identical effects on the low-shear viscosity of F-actin (data 
not shown). The results from these assays confirm that the 
different structures of the 13 subunit isoforms neither con- 
fer a difference in the steady-state equilibrium binding to 
F-actin nor impart selective binding  of CP-131 and  CP-132 
to  different  actin  isoforms.  The  reason  for  the  evolution 
and  conservation  of different  COOH-terminal  13  subunit 
peptides  in  vertebrates  remains  unknown.  The  isoforms 
are targeted to different locations in the cell (54). At those 
locations, the isoforms presumably possess some differen- 
tiation of function that justifies their targeting. 
Regulation of Capping Protein 
Regulation  of capping activity is  one  mechanism to alter 
the availability of free barbed  ends in cells. Three poten- 
tial  regulators  of capping  protein  activity have  been  de- 
scribed based on their interactions with capping protein in 
vitro:  anionic  phospholipids,  especially  PIPe  (30),  heat 
shock  cognate  protein  70 (Hsc70)  (20, 28)  and  $100 pro- 
teins (35). 
Uncapping Actin Filaments by Anionic Phospholipids 
PIPe  rapidly and  efficiently promoted  the  dissociation  of 
capping protein from actin filaments (Fig. 7 A). Thus, PIP2 
could be the signaI for uncapping barbed ends during actin 
remodelling in vivo. A  typical uncapping  assay using CP- 
131 and ct-actin is shown in Fig. 7 A; similar results were ob- 
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Figure 5.  CP-131 (upper) and CP-~32 (lower) have similar effects 
on depolymerization of actin filaments. Capping proteins were 
incubated with 5 p,M F-actin for 5 min before dilution of the solu- 
tion 25-fold into G buffer. The concentration of capping protein 
(in nM) in the F-actin-capping  protein mixture before dilution is 
indicated beside each curve, Pyrene-actin fluorescence is plotted 
versus time after dilution. 
tained using CP-132 and 13~-actin (data not shown). In this 
assay designed specifically to look at uncapping, PIP  2 at 36 
IxM was  added  to  a  polymerization reaction containing 
capping protein at a time when most of the actin filaments 
were capped (arrow at 340 s for curve 3 in Fig. 7 A). The 
rate of actin polymerization increased dramatically upon 
addition of the PIP2 (compare curves 2 and 3 in Fig. 7 A), 
approaching the maximal rate of actin polymerization in 
the absence of capping protein (compare curves 1 and 3 in 
Fig. 7 A). Cytochalasin D at 20 nM inhibited the increased 
rate of polymerization induced by PIP2 (curve 4 in Fig. 7 A), 
indicating that free barbed ends had been created. PIP2 
had no effect on the rate of polymerization of actin alone 
Figure 7.  PIP2  promotes the dissociation of capping protein from 
actin filaments. (A) Polymerization of 2 ~M a-actin at barbed 
ends was  nucleated by spectrin-F-actin seeds  in the  presence 
(curves 2, 3, and 4) and absence (curve 1) of 12 nM CP-I31. After 
340 s, 36 p,M PIP2 was added to reactions shown in curves 3 and 4 
(arrow). Cytochalasin D at 20 nM also was added at 340 s to the 
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Figure 6.  CP-IM and CP-132 have similar actin filament nucle- 
ation activity. CP-[31 or CP-132 at 50 and 10 nM were incubated 5 
rain with 5 I~M monomeric c(-actin. Pyrene-actin fluorescence is 
plotted versus time after addition of MKEI buffer to initiate poly- 
merization, 
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reaction in curve 4. The immediate increase in fluorescence ob- 
served upon addition of PIP2 may be due to light scattering by the 
PIP2 (39), PIP2 induced a large increase in the rate of actin poly- 
merization from capped actin filaments (compare curves 2 and 3) 
that approached the rate of polymerization  of actin alone (curve 1). 
Cytochalasin D inhibited the increase in actin polymerization  due 
to PIPz (curve 4). Similar results were obtained in experiments 
using CP-132 with either a-actin or 13~/-actin  (data not shown). (B) 
Comparison of the effects  of different phospholipids on uncap- 
ping actin filaments. Assays like those in A were performed with 
2 /~M a-actin, 4 nM CP-131, and varying concentrations of PIPs, 
PIP2, P/P, PI, and PA. Uncapping  activity is defined as the rate of 
actin polymerization, calculated from the slope of the pyrene flu- 
orescence versus  time, during the early linear phase after addi- 
tion of the phospholipid. 
The Journal  of Cell Biology, Volume 135, 1996  174 (data not shown), thus, PIP2 did not alter actin monomer 
interactions and did not sever filaments. Assays using cap- 
ping protein-capped F-actin seeds in place of spectrin-F- 
actin seeds gave similar results (data not shown). 
Concentrations of PIP2 >  ~40  ixM did not further in- 
crease the rate of polymerization. The half maximal effect 
was at ,'-~20 p~M PIP  e (Fig. 7 B). PIP  2 was equally effective 
in  uncapping  when  present  as  mixed  lipid  vesicles with 
phosphatidylethanolamine (molar ratios of PIPz/PE of 1:2 
and  1:9,  data not  shown).  PIP also  uncapped  actin fila- 
ments but was less efficient than PIP  2 (Fig. 7B). PI, PA, 
and, surprisingly, PIP3 had little or no uncapping activity 
(Fig. 7 B). PIP3 has been proposed to control transient ac- 
tin polymerization (43) since changes in the levels of PIP3 
in  platelets  (41)  and  neutrophils  (19)  parallel  the  time 
course of actin polymerization and subsequent depolymer- 
ization in stimulated cells. We report the first description 
of the effect of PIP3 on the activity of an actin binding pro- 
tein and find that PIP3 did not uncap filaments at all and 
was less potent than PIP2 in inhibiting capping activity (see 
below). Thus, the different structural features of polyphos- 
phoinositides, not  merely their anionic character, deter- 
mine how they interact with capping protein. 
The uncapping  activity of PIP  2 depended critically on 
the concentration of Mg2+; 0.2 mM MgC12 supported high 
activity. At 2 mM MgC12, PIP2 induced a far smaller in- 
crease in the rate of actin polymerization in the uncapping 
assay (data  not shown).  This slight effect was similar to 
that seen previously by Heiss et al., using 2 mM MgCl2 and 
a  different experimental design (30). The dependence of 
the PIPe-induced actin polymerization on [Mg  e+] may be 
due to aggregation of PIP2 by divalent cations (38). The 
free [Mg  e÷] in cells is ~0.5 mM but is heterogeneously dis- 
tributed. In peripheral regions near the plasma membrane 
where  PIP2-mediated  signaling  should  occur,  the  free 
[Mg  e+] is significantly lower (17, 52). Thus, the low [Mg  2÷] 
necessary for optimal PIP2-mediated uncapping is likely to 
exist in vivo. 
Inhibition of Capping Activity by Phosphoinositides 
The capping activity of CP-132 was inhibited in a concen- 
tration-dependent manner  by PIP2  (Fig.  8  B),  as  previ- 
ously observed for CP-131 (Fig. 8 A) (30). PIP  3 also inhib- 
ited capping protein but concentrations ~10-fold higher 
than those required for inhibition by PIP2, were required 
for inhibition of capping activity by PIP3 (Fig. 8 C). 
Effects of Hsc  70 on Capping Protein Activity 
Regulation of Dictyostelium capping protein by Hsc70 was 
suggested by the existence of a  stable complex between 
Hsc70 and capping protein in whole cell extracts (21, 28) 
and by an Hsc70-induced increase in capping activity of 
mixtures of bacterially expressed capping protein c~ and [3 
subunits (28). The availability of purified capping protein 
and Hsc70 allowed us to test whether or not Hsc70 directly 
alters capping protein's actin binding activity. Hsc70 from 
bovine brain in the presence of either 5 mM ATP or 5 mM 
ADP had no effect on the capping activity of CP-[31 or CP- 
132 as measured in actin depolymerization assays (Fig. 9). 
Hsc70 also did not promote uncapping (data not shown). 
We found no evidence for formation of a stable complex 
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Figure 8.  PIP2 and PIP3 inhibit the actin capping activity of cap- 
ping protein. 50 nM CP-131 (A and C) or 50 nM CPq32 (B) was in- 
cubated with varying amounts of PIPe (A and B) or PIP3 (C) for 5 
min at room temperature in G buffer. 5 IxM F-a-actin was added 
to the PIPe-capping protein mixture and the mixture was diluted 
in G buffer. Pyrene-actin fluorescence is plotted versus time after 
dilution. The concentration  of PIPe or PIP3 incubated  with the 
capping protein is indicated beside each curve. 
of Hsc70 and capping protein. Purified CP-131 or CP-132 
and Hsc70 were mixed under conditions that stabilize the 
complex from Dictyostelium (21). The mixture was  sub- 
jected to gel filtration analysis and to immunoprecipitation 
using antibodies to either capping protein or Hsc70 (28). 
Results  from  both  sets  of  experiments  indicated  that 
Hsc70 did not associate with capping protein. 
Taken together, our results indicate that Hsc70 does not 
bind to or influence the activity of capping protein, which 
is  in contrast with conclusions of previous studies  (28). 
Recent  experiments  on  purified  Dictyostelium capping 
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Figure 9.  Hsc70  has no effect on the actin capping activity of CP-f31 
(upper) and  CP-~2  (lower) in  actin  depolymerization  assays. 
Hsc70, in the presence of 5 mM Mg-ADP, was incubated at vary- 
ing molar ratios with CP-131 and CP-[32 for 5 min at room temper- 
ature before addition to 5 ~M F-oL-actin. The mixture was diluted 
into G buffer, and the change in pyrene fluorescence  was moni- 
tored  with  time after dilution.  Experiments performed in  the 
presence  of 5  mM  Mg-ATP  gave  identical  results  (data  not 
shown). 
protein also conclude that the isoform of Hsc70 that copu- 
rifles with capping protein does not regulate capping pro- 
tein (21). In the previous studies, which used whole cell ex- 
tracts, Hsc70 may have acted as a chaperone to promote 
the  folding  of capping protein.  Alternative  explanations 
for the difference between our results and the earlier stud- 
ies  include  that  bovine  Hsc70  may  not  interact  with 
chicken  capping  protein  and  that  a  specific  isoform  of 
Hsc70, not the one tested here, interacts with capping pro- 
tein. 
Effects of S I O0 Proteins on Capping Protein Activity 
$100  proteins have been proposed to regulate actin fila- 
ment assembly in vivo via a calcium-dependent interaction 
with capping protein  (35,  36).  We tested whether or not 
$100 proteins alter the interaction of CP-[31 with c~-actin in 
the presence and absence of CaCl2.  Three types of experi- 
ments were performed: falling ball viscometry assays, actin 
depolymerization  assays,  and  assays  for  uncapping  of 
capped actin filaments. We find that S100 protein binding 
to capping protein does not alter capping protein's interac- 
tion with actin (data not shown); therefore, capping pro- 
tein can simultaneously bind actin and $100 protein. Cap- 
ping protein may serve to position $100 protein at Z-disks, 
the location of both capping protein (11) and S100a0  (23) 
in muscle. The importance of locating $100 protein in the 
sarcomere  is  underscored  by  the  recent  finding  that 
S100A12  activated in a CaZ+-dependent manner the kinase 
domain of twitchin, which may be important for organiz- 
ing muscle structure and regulating contraction (29). 
Discussion 
Implications  of Kinetics of Capping Protein 
Knowing the rate constants for the interaction of capping 
protein with actin filaments in vitro is necessary to under- 
stand how capping protein may regulate the dynamics of 
actin assembly in vivo. Kinetic rate constants allow one to 
predict  the  half-lives for free and  capped  actin  filament 
barbed ends and to predict the amount of actin polymer- 
ized during the time a barbed end is free. The rate of un- 
capping can also be compared with the rate of creation of 
free barbed ends in cells stimulated by agents that induce 
rapid changes in the actin cytoskeleton. 
Implications  of the On-rate Constant 
The on-rate constant of 3.0 ~M-Is  -1, together with a cellu- 
lar concentration of capping protein from 0.2 to 2 I~M (14, 
18, 34, 47), predicts a half-life for a free barbed end in vivo 
of 0.1-1 s. Actin polymerization from free barbed ends de- 
pends  on  the  concentration  of available  actin  subunits, 
which includes the pools of profilin-actin and free G-actin 
monomer (49, 51). At an upper limit for the actin subunit 
pool in vivo of ~100 p~M (8), a free barbed end could grow 
from 0.3  to 3  ~zm during 0.1  to 1 s. Thus, actin filaments 
with free barbed ends could elongate to lengths observed 
for  actin  filaments  in  vivo  (0.5-0.6  ~m  in  macrophages 
[26]; 0.18-2.1  ~m in neutrophils  [7]; ~0.3  ~m in Listeria 
tails [57]) before being capped. 
Implications  of the Off-rate  Constant 
The off-rate constant  of 4  x  10 -4 s -1  for dissociation of 
capping  protein  from  F-actin  predicts  a  half-life  for  a 
capped  barbed  end  of ~28  min.  This  half-life  is  much 
longer than the time observed for the increase in number 
of barbed ends and in F-actin in cells responding to stim- 
uli. For example, within 90 s after neutrophils encountered 
chemoattractant, the amount of F-actin and the total num- 
ber of actin filaments more than doubled (7). Also, within 
30 s after stimulation of platelets with thrombin, the num- 
ber of free barbed ends increased from ~50 to ~500 per 
platelet (25, 27). This large discrepancy between the rapid 
rate for actin remodelling in vivo and the slow rate for dis- 
sociation of capping protein from barbed ends  led  us to 
search  for  factors  that  accelerate  uncapping  of  barbed 
ends.  Regulators that cause uncapping also may account 
for the discrepancy between the apparent Ka of ~100 nM 
for Dictyostelium capping  protein  in  whole  cell  extracts 
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ping protein (21). 
Uncapping Actin Filaments by Phosphoinositides 
Our tests of several possible regulators of capping protein 
indicate  that  the  polyphosphoinositides,  PIP2  and,  to  a 
lesser extent, PIP, induce the dissociation of capping pro- 
tein from barbed ends. It is likely that PIP2 binds directly 
to capping protein and increases its rate constant for disso- 
ciation from F-actin. Kinetic simulations based on such a 
model predict the  observed changes in  actin polymeriza- 
tion well (see description of simulations in Materials and 
Methods).  In  contrast,  simulations  of a  model  in  which 
PIP2  sequesters  free  capping  protein  after  it  dissociates 
from barbed ends at the usual slow rate do not fit the ex- 
perimental data. 
Is the  PIP2-induced  actin  polymerization from capped 
filaments  observed  in  vitro  sufficient  to  account  for  in- 
creased actin polymerization in stimulated cells? In plate- 
lets, ~500 new free barbed ends were created from ~2,000 
capped filaments by 30-60 s after stimulation with throm- 
bin  (27).  At  conditions  for maximal uncapping  in  vitro, 
PIP2 decreased the half-life for a capped barbed end from 
~28 min to ~46 s. We calculate from a tile of 46 s that 500 
free barbed ends could be created in ~19 s. Thus, the rate 
of PIP2-induced  uncapping  observed in  vitro is sufficient 
to account for the number of free barbed ends that appear 
in stimulated platelets. 
Signal  transduction  pathways  in  which  phosphoinosi- 
tides function require that the levels of phosphoinositides 
change  in  response  to  the  stimulus.  However,  the  total 
mass  of PIP2  decreases,  rather  than  increases  following 
stimulation of platelets (59). On the other hand, turnover 
of PIP2 is increased in platelets upon stimulation (1), rais- 
ing the possibility that local changes in the PIP  2 concentra- 
tion  occur  during  signaling.  The  identification  in  some 
cells of specialized membrane domains enriched  in  PIP2, 
glycosphingolipids, and a polyphosphoinositide phosphatase 
(4, 32) supports the idea that the PIP2 concentration may 
vary spatially. 
Model for Actin Assembly In Vivo 
We propose a  mechanism for remodeling the  actin cyto- 
skeleton in stimulated cells that accounts for the increases 
in  the  number of actin filaments, number of free barbed 
ends, and amount of F-actin. Our model is based on three 
processes: uncapping of barbed ends by the action of PIP2, 
polymerization at the free barbed ends, and severing the 
long  actin  filaments  (Fig.  10).  First,  PIP2  in  the  plasma 
membrane (Fig. 10, green) uncaps actin filaments and gen- 
erates free barbed ends near the membrane. Polymeriza- 
tion  at free barbed ends lengthens  the  filaments and ex- 
tends lamellae and filopodia. PIP2 also inhibits capping of 
free barbed ends, thereby prolonging filament elongation. 
Next,  the  elongated  filaments  break,  creating  new  fila- 
ments with free pointed  and  barbed  ends.  Finally,  when 
the  local  PIP2  level decreases,  capping protein  caps the 
free barbed ends to stop polymerization. 
We  demonstrate  here  that  PIP2 does uncap  actin  fila- 
ment barbed  ends.  PIP  2 is part  of the  signaling pathway 
that induces  actin polymerization in permeabilized plate- 
Figure 10.  Model for actin assembly in stimulated cells. The PIP2 
concentration increases in a  region of the plasma membrane in 
response  to  a  local  extracellular  stimulus  (green).  PIP2  causes 
capping protein (red circles) to dissociate from the barbed ends of 
actin filaments.  Actin filaments grow  at  their free  barbed ends 
and  push  the  plasma  membrane  outward.  Elongated  filaments 
then break, because of either mechanical forces or the action of a 
severing protein. Finally, new free barbed ends situated far from 
the membrane where capping protein is active become capped. 
The net effects are protrusion of the plasma membrane and the 
creation  of new  filaments the  same  length  as  the  existing fila- 
ments, of new pointed ends, and of new barbed ends. 
lets  (27).  Furthermore,  capping protein  is  released  from 
platelet cytoskeletons upon stimulation by thrombin (47). 
These data are consistent with the first steps of our model 
where signals mediated by PIPe induce  actin  remodeling 
by uncapping barbed ends. 
One  aspect of actin remodeling in vivo that cannot be 
explained solely by uncapping is an increase in the number 
of  actin  filaments.  During  platelet  activation,  the  total 
number of filaments increases from 2,000 to 2,500 per cell 
(27). More dramatic are the findings in stimulated neutro- 
phils, where the number of actin filaments increases from 
1.7  x  105 to 4  ×  105 per cell without a change in actin fila- 
ment length (7). Clearly, additional processes, such as sev- 
ering or de novo nucleation, two processes that create new 
filaments, are required to explain these data. 
We  favor a  mechanism where long actin filaments are 
fragmented to create new filaments. One possible mecha- 
nism  for breaking filaments is via mechanical  forces ex- 
erted on them by myosins or other factors. Alternatively, 
actin  filament  severing  proteins  of  the  ADF/cofilin  or 
Schafer et al. Dynamics of Capping Protein  177 gelsolin  families  may  serve  this  role.  ADF/cofilins  are 
ubiquitous, present at high concentrations in vivo, and can 
be  regulated  by  phosphorylation and  polyphosphoinosi- 
tides (for review see [45]). The contribution to severing by 
gelsolin may be minor since platelets lacking gelsolin as- 
semble  actin normally in response to thrombin (60). The 
gelsolin analogue adseverin/scinderin is another candidate 
(for review see [53]). 
Nucleation of actin filaments de novo from actin mono- 
mers is an alternative mechanism to create new filaments. 
Capping protein nucleates actin polymerization in vitro at 
a rapid rate (6). However, filaments nucleated by capping 
protein are capped at their barbed ends, thus, free barbed 
ends would not increase unless the new filaments were ei- 
ther uncapped  or severed.  In  addition, PIPe  inhibits the 
nucleation activity of capping protein (30); thus, increased 
PIPe would inhibit, rather than promote, actin polymeriza- 
tion nucleated by capping protein. 
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Note Added in Proof. Barkalow et al. recently reported that either PIP2 or 
a thrombin activiating peptide, TRAF, induces the release of capping pro- 
tein from the cytoskeleton of permeabilized platelets (Fig. 8 in Barkalow, 
K., W. Witke, D.J. Kwiatkowski, and J.H. Hartwig. 1996. J. Cell Biol. 134: 
389-399). These data support the initial step of our model (Fig. 10) where 
polyphosphoinositides release capping protein from actin filaments to cre- 
ate free barbed ends. 
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